Serotonin dopamine interaction: experimental evidence and therapeutic relevance
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2008
|
| Ausgabe: | 1. ed. |
| Schriftenreihe: | Progress in brain research
172 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XV, 665 S. Ill., graph. Darst. |
| ISBN: | 9780444532350 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV035124669 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 081028s2008 ad|| |||| 00||| eng d | ||
| 020 | |a 9780444532350 |9 978-0-444-53235-0 | ||
| 035 | |a (OCoLC)233617614 | ||
| 035 | |a (DE-599)HBZHT015704405 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-20 | ||
| 050 | 0 | |a QP | |
| 082 | 0 | |a 612.8042 |2 22 | |
| 245 | 1 | 0 | |a Serotonin dopamine interaction |b experimental evidence and therapeutic relevance |c ed. by Giuseppe Di Giovanni ... |
| 246 | 1 | |a Serotonin-dopamine interaction | |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2008 | |
| 300 | |a XV, 665 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Progress in brain research |v 172 | |
| 650 | 4 | |a Dopamine | |
| 650 | 4 | |a Neurochimie | |
| 650 | 4 | |a Neurotransmetteurs | |
| 650 | 4 | |a Sérotonine | |
| 650 | 4 | |a Dopamine | |
| 650 | 4 | |a Dopamine Agonists | |
| 650 | 4 | |a Dopamine |x physiology | |
| 650 | 4 | |a Drug Interactions | |
| 650 | 4 | |a Neurochemistry | |
| 650 | 4 | |a Neurotransmitters | |
| 650 | 4 | |a Serotonin | |
| 650 | 4 | |a Serotonin Agonists | |
| 650 | 4 | |a Serotonin |x physiology | |
| 700 | 1 | |a Di Giovanni, Giuseppe |4 edt | |
| 830 | 0 | |a Progress in brain research |v 172 |w (DE-604)BV008000363 |9 172 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016792273&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016792273 | ||
Datensatz im Suchindex
| _version_ | 1804138104196431872 |
|---|---|
| adam_text | Contents
List of contributors v
Preface ix
Dedication xi
I. Serotonin-Dopamine Interactions in the Central Nervous System
1. Serotonin-dopamine interaction: an overview
E. Esposito, V. Di Matteo and G. Di Giovanni (Santa Maria Imbaro,
Chieti and Palermo, Italy) 3
2. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies
V. Di Matteo, G. Di Giovanni, M. Pierucci and E. Esposito
(Santa Maria Imbaro, Chieti and Palermo, Italy) 7
3. Serotonin-dopamine interaction: electrophysiological evidence
G. Di Giovanni, V. Di Matteo, M. Pierucci and E. Esposito
(Palermo and Santa Maria Imbaro, Chieti, Italy) 45
4. Functional genetic polymorphisms in serotonin and dopamine gene Systems and
their significance in behavioural disorders
U.M. D Souza and I.W. Craig (London, UK) 73
II. Serotonin-Dopamine Interactions in Schizophrenia
5. Distribution of 5-HT and DA receptors in primate prefrontal cortex:
implications for pathophysiology and treatment
J. de Almeida, J.M. Palacios and G. Mengod (Barcelona. Spain) 101
6. Alterations of dopamine and serotonin transmission in schizophrenia
G. Remington (Toronto, ON, Canada) 117
7. Serotonin and dopamine interactions in psychosis prevention
N.M. Richtand and R.K. McNamara (Cincinnati. OH, USA) 141
8. Role of serotonin and dopamine receptor binding in antipsychotic efficacy
N.M. Richtand. J.A. Welge. A.D. Logue. P.E. Keck Jr..
S.M. Strakowski and R.K. McNamara (Cincinnati, OH, USA) 155
xiii
xiv
9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic Systems
H.Y. Meltzer and M. Huang (Nashville, TN, USA) 177
10. Neuropharmacology of second-generation antipsychotic drugs: a validity of
the serotonin-dopamine hypothesis
T. Kuroki, N. Nagao and T. Nakahara (Kanzaki, Japan) 199
11. Serotonin-dopamine interactions: implications for the design of
novel therapeutic agents for psychiatric disorders
M.D. Wood and P.W. Wren (Harlow, UK and Verona, Italy) 213
III. Serotonin-Dopamine Interactions in Depression
12. The dorsal raphe nucleus and serotonin: implications for neuroplasticity
linked to major depression and Alzheimer s disease
K.A. Michelsen, J. Prickaerts and H.W.M. Steinbusch
(Maastricht, The Netherlands) 233
13. Dynamics of the dopaminergic System as a key component to the understanding of depression
G. Yadid and A. Friedman (Ramat-Gan, Israel) 265
14. Physiological and therapeutic relevance of constitutive activity
of 5-HT2a and 5-HT2c receptors for the treatment of depression
K.A. Berg, J.A. Harvey, U. Spampinato and W.P. Clarke
(San Antonio, TX, Philadelphia, PA, USA and Bordeaux Cedex, France) 287
15. The role of dopamine and serotonin in suicidal behaviour and aggression
E. Ryding, M. Lindström and L.Träskman-Bendz (Stockholm and Lund, Sweden) . . 307
IV. Serotonin-Dopamine Interactions in Drug Addiction
16. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse
M.J. Bubar and K.A. Cunningham (Galveston, TX, USA) 319
17. Pharmacological inhibition of dopamine and serotonin activity blocks
spontaneous and cocaine-activated behaviour
R.J. Carey, J.P. Huston and C.P. Müller (NY, USA, Düsseldorf, Germany
and London, UK) 347
18. Serotonin receptors as potential targets for modulation of nicotine use and dependence
P.J. Fletcher, A. Dzung Le and G.A. Higgins (Toronto, ON, Canada) 361
19. Dopamine/serotonin releasers as medications for stimulant addictions
R.B. Rothman, B.E. Blough and M.H. Baumann
(Baltimore. MD and Triangle Park, NC, USA) 385
20. PTEN-5-HT2C coupling: a new target for treating drug addiction
J.-C. Maillet, Y. Zhang, X. Li and X. Zhang (Ottawa, ON, Canada) 407
XV
V. Serotonin-Dopamine Interactions in Motor Disorders
21. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for
Parkinson s disease and other motor disorders
V. Di Matteo, M. Pierucci, E. Esposito, G. Crescimanno, A. Benigno and
G. Di Giovanni (Santa Maria Imbaro, Chieti and Palermo, Italy) 423
22. Serotonin-dopamine interaction in the induction and maintenance
of L-DOPA-induced dyskinesias
M. Carta, T. Carlsson, A. Mufioz, D. Kirik and A. Björklund (Lund, Sweden) 465
23. Parkinson s disease — opportunities for novel therapeutics to reduce the
Problems of levodopa therapy
S.H. Fox, R. Chuang and J.M. Brotchie (Toronto. ON, Canada) 479
24. Neurobiological basis of serotonin-dopamine antagonists in the treatment of
Gilles de la Tourette syndrome
T.D.L. Steeves and S.H. Fox (Toronto, ON, Canada) 495
VI. Serotonin-Dopamine Interactions in Attentional Processes, Learning and Memory
25. Serotonergic and dopaminergic modulation of attentional processes
V. Boulougouris and E. Tsaltas (Cambridge, UK and Athens, Greece) 517
26. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD)
R.D. Oades (Essen, Germany) 543
27. Serotonin/dopamine interaction in learning
M.E. Olvera-Cortes, P. Anguiano-Rodriguez, M.Ä. Lopez-Väzquez and
J.M.C. Alfaro (Morelia, Mich., Mexico) 567
28. Serotonin/dopamine interaction in memory formation
I. Gonzalez-Burgos and A. Feria-Velasco (Guadalajara, Jal., Mexico) 603
29. The roles of dopamine and serotonin, and of their receptors. in regulating sleep and waking
J.M. Monti and H. Jantos (Montevideo. Uruguay) 625
Subject Index 647
See Color Plate Section at the end of this book
|
| adam_txt |
Contents
List of contributors v
Preface ix
Dedication xi
I. Serotonin-Dopamine Interactions in the Central Nervous System
1. Serotonin-dopamine interaction: an overview
E. Esposito, V. Di Matteo and G. Di Giovanni (Santa Maria Imbaro,
Chieti and Palermo, Italy) 3
2. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies
V. Di Matteo, G. Di Giovanni, M. Pierucci and E. Esposito
(Santa Maria Imbaro, Chieti and Palermo, Italy) 7
3. Serotonin-dopamine interaction: electrophysiological evidence
G. Di Giovanni, V. Di Matteo, M. Pierucci and E. Esposito
(Palermo and Santa Maria Imbaro, Chieti, Italy) 45
4. Functional genetic polymorphisms in serotonin and dopamine gene Systems and
their significance in behavioural disorders
U.M. D'Souza and I.W. Craig (London, UK) 73
II. Serotonin-Dopamine Interactions in Schizophrenia
5. Distribution of 5-HT and DA receptors in primate prefrontal cortex:
implications for pathophysiology and treatment
J. de Almeida, J.M. Palacios and G. Mengod (Barcelona. Spain) 101
6. Alterations of dopamine and serotonin transmission in schizophrenia
G. Remington (Toronto, ON, Canada) 117
7. Serotonin and dopamine interactions in psychosis prevention
N.M. Richtand and R.K. McNamara (Cincinnati. OH, USA) 141
8. Role of serotonin and dopamine receptor binding in antipsychotic efficacy
N.M. Richtand. J.A. Welge. A.D. Logue. P.E. Keck Jr.
S.M. Strakowski and R.K. McNamara (Cincinnati, OH, USA) 155
xiii
xiv
9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic Systems
H.Y. Meltzer and M. Huang (Nashville, TN, USA) 177
10. Neuropharmacology of second-generation antipsychotic drugs: a validity of
the serotonin-dopamine hypothesis
T. Kuroki, N. Nagao and T. Nakahara (Kanzaki, Japan) 199
11. Serotonin-dopamine interactions: implications for the design of
novel therapeutic agents for psychiatric disorders
M.D. Wood and P.W. Wren (Harlow, UK and Verona, Italy) 213
III. Serotonin-Dopamine Interactions in Depression
12. The dorsal raphe nucleus and serotonin: implications for neuroplasticity
linked to major depression and Alzheimer's disease
K.A. Michelsen, J. Prickaerts and H.W.M. Steinbusch
(Maastricht, The Netherlands) 233
13. Dynamics of the dopaminergic System as a key component to the understanding of depression
G. Yadid and A. Friedman (Ramat-Gan, Israel) 265
14. Physiological and therapeutic relevance of constitutive activity
of 5-HT2a and 5-HT2c receptors for the treatment of depression
K.A. Berg, J.A. Harvey, U. Spampinato and W.P. Clarke
(San Antonio, TX, Philadelphia, PA, USA and Bordeaux Cedex, France) 287
15. The role of dopamine and serotonin in suicidal behaviour and aggression
E. Ryding, M. Lindström and L.Träskman-Bendz (Stockholm and Lund, Sweden) . . 307
IV. Serotonin-Dopamine Interactions in Drug Addiction
16. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse
M.J. Bubar and K.A. Cunningham (Galveston, TX, USA) 319
17. Pharmacological inhibition of dopamine and serotonin activity blocks
spontaneous and cocaine-activated behaviour
R.J. Carey, J.P. Huston and C.P. Müller (NY, USA, Düsseldorf, Germany
and London, UK) 347
18. Serotonin receptors as potential targets for modulation of nicotine use and dependence
P.J. Fletcher, A. Dzung Le and G.A. Higgins (Toronto, ON, Canada) 361
19. Dopamine/serotonin releasers as medications for stimulant addictions
R.B. Rothman, B.E. Blough and M.H. Baumann
(Baltimore. MD and Triangle Park, NC, USA) 385
20. PTEN-5-HT2C coupling: a new target for treating drug addiction
J.-C. Maillet, Y. Zhang, X. Li and X. Zhang (Ottawa, ON, Canada) 407
XV
V. Serotonin-Dopamine Interactions in Motor Disorders
21. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for
Parkinson's disease and other motor disorders
V. Di Matteo, M. Pierucci, E. Esposito, G. Crescimanno, A. Benigno and
G. Di Giovanni (Santa Maria Imbaro, Chieti and Palermo, Italy) 423
22. Serotonin-dopamine interaction in the induction and maintenance
of L-DOPA-induced dyskinesias
M. Carta, T. Carlsson, A. Mufioz, D. Kirik and A. Björklund (Lund, Sweden) 465
23. Parkinson's disease — opportunities for novel therapeutics to reduce the
Problems of levodopa therapy
S.H. Fox, R. Chuang and J.M. Brotchie (Toronto. ON, Canada) 479
24. Neurobiological basis of serotonin-dopamine antagonists in the treatment of
Gilles de la Tourette syndrome
T.D.L. Steeves and S.H. Fox (Toronto, ON, Canada) 495
VI. Serotonin-Dopamine Interactions in Attentional Processes, Learning and Memory
25. Serotonergic and dopaminergic modulation of attentional processes
V. Boulougouris and E. Tsaltas (Cambridge, UK and Athens, Greece) 517
26. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD)
R.D. Oades (Essen, Germany) 543
27. Serotonin/dopamine interaction in learning
M.E. Olvera-Cortes, P. Anguiano-Rodriguez, M.Ä. Lopez-Väzquez and
J.M.C. Alfaro (Morelia, Mich., Mexico) 567
28. Serotonin/dopamine interaction in memory formation
I. Gonzalez-Burgos and A. Feria-Velasco (Guadalajara, Jal., Mexico) 603
29. The roles of dopamine and serotonin, and of their receptors. in regulating sleep and waking
J.M. Monti and H. Jantos (Montevideo. Uruguay) 625
Subject Index 647
See Color Plate Section at the end of this book |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author2 | Di Giovanni, Giuseppe |
| author2_role | edt |
| author2_variant | g g d gg ggd |
| author_facet | Di Giovanni, Giuseppe |
| building | Verbundindex |
| bvnumber | BV035124669 |
| callnumber-first | Q - Science |
| callnumber-label | QP |
| callnumber-raw | QP |
| callnumber-search | QP |
| callnumber-sort | QP |
| callnumber-subject | QP - Physiology |
| ctrlnum | (OCoLC)233617614 (DE-599)HBZHT015704405 |
| dewey-full | 612.8042 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 612 - Human physiology |
| dewey-raw | 612.8042 |
| dewey-search | 612.8042 |
| dewey-sort | 3612.8042 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01678nam a2200493 cb4500</leader><controlfield tag="001">BV035124669</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">081028s2008 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780444532350</subfield><subfield code="9">978-0-444-53235-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)233617614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT015704405</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">612.8042</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serotonin dopamine interaction</subfield><subfield code="b">experimental evidence and therapeutic relevance</subfield><subfield code="c">ed. by Giuseppe Di Giovanni ...</subfield></datafield><datafield tag="246" ind1="1" ind2=" "><subfield code="a">Serotonin-dopamine interaction</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 665 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Progress in brain research</subfield><subfield code="v">172</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurochimie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotransmetteurs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sérotonine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine Agonists</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotransmitters</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin Agonists</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Di Giovanni, Giuseppe</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Progress in brain research</subfield><subfield code="v">172</subfield><subfield code="w">(DE-604)BV008000363</subfield><subfield code="9">172</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016792273&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016792273</subfield></datafield></record></collection> |
| id | DE-604.BV035124669 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:22:23Z |
| indexdate | 2024-07-09T21:22:53Z |
| institution | BVB |
| isbn | 9780444532350 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016792273 |
| oclc_num | 233617614 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-20 |
| physical | XV, 665 S. Ill., graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Elsevier |
| record_format | marc |
| series | Progress in brain research |
| series2 | Progress in brain research |
| spelling | Serotonin dopamine interaction experimental evidence and therapeutic relevance ed. by Giuseppe Di Giovanni ... Serotonin-dopamine interaction 1. ed. Amsterdam [u.a.] Elsevier 2008 XV, 665 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Progress in brain research 172 Dopamine Neurochimie Neurotransmetteurs Sérotonine Dopamine Agonists Dopamine physiology Drug Interactions Neurochemistry Neurotransmitters Serotonin Serotonin Agonists Serotonin physiology Di Giovanni, Giuseppe edt Progress in brain research 172 (DE-604)BV008000363 172 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016792273&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Serotonin dopamine interaction experimental evidence and therapeutic relevance Progress in brain research Dopamine Neurochimie Neurotransmetteurs Sérotonine Dopamine Agonists Dopamine physiology Drug Interactions Neurochemistry Neurotransmitters Serotonin Serotonin Agonists Serotonin physiology |
| title | Serotonin dopamine interaction experimental evidence and therapeutic relevance |
| title_alt | Serotonin-dopamine interaction |
| title_auth | Serotonin dopamine interaction experimental evidence and therapeutic relevance |
| title_exact_search | Serotonin dopamine interaction experimental evidence and therapeutic relevance |
| title_exact_search_txtP | Serotonin dopamine interaction experimental evidence and therapeutic relevance |
| title_full | Serotonin dopamine interaction experimental evidence and therapeutic relevance ed. by Giuseppe Di Giovanni ... |
| title_fullStr | Serotonin dopamine interaction experimental evidence and therapeutic relevance ed. by Giuseppe Di Giovanni ... |
| title_full_unstemmed | Serotonin dopamine interaction experimental evidence and therapeutic relevance ed. by Giuseppe Di Giovanni ... |
| title_short | Serotonin dopamine interaction |
| title_sort | serotonin dopamine interaction experimental evidence and therapeutic relevance |
| title_sub | experimental evidence and therapeutic relevance |
| topic | Dopamine Neurochimie Neurotransmetteurs Sérotonine Dopamine Agonists Dopamine physiology Drug Interactions Neurochemistry Neurotransmitters Serotonin Serotonin Agonists Serotonin physiology |
| topic_facet | Dopamine Neurochimie Neurotransmetteurs Sérotonine Dopamine Agonists Dopamine physiology Drug Interactions Neurochemistry Neurotransmitters Serotonin Serotonin Agonists Serotonin physiology |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016792273&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV008000363 |
| work_keys_str_mv | AT digiovannigiuseppe serotonindopamineinteractionexperimentalevidenceandtherapeuticrelevance AT digiovannigiuseppe serotonindopamineinteraction |